Skip to content
Shuttingdown

Silexion Therapeutics Corp

Biological Products, (No Diagnostic Substances) · RAMAT GAN

Distress signal

Moderate confidence (50%)

Updated Oct 17, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Silexion Therapeutics Corp received a delisting notice from its exchange (Sep 25, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Silexion Therapeutics Corp received a delisting notice from its exchange

    Sep 25, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Additional Nasdaq Staff Determination; Nasdaq Hearings Panel Consideration On September 25, 2026, Silexion Therapeutics Corp (the Company or Silexion ) received a letter from the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, for the 30 consecutive business days preceding the letter, the closing bid price of the Company s ordinary shares, par value $0.135 per share ( ordinary share s ), was below the minimum $1.00 pe…”

  2. Silexion Therapeutics Corp received a delisting notice from its exchange

    Aug 21, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On August 18, 2026, Silexion Therapeutics Corp, a Cayman Islands exempted company (the Company , we , us or our ) received a delisting notice from the Nasdaq Listing Qualifications Department in respect of a listing deficiency relating to our non-compliance with the minimum shareholders equity requirement for continued listing on The Nasdaq Capital Market. That delisting notice is subject to the Company s right to request an appeal of the determination before a Nasdaq Hearings Panel (a…”

Company information

Founded
—
Employees (estimate)
—
Industry
Biological Products, (No Diagnostic Substances)
Subindustry
—
Listing
SEC lists the tickers SLXN and SLXNW on Nasdaq.
SEC CIK
0002022416
Website
—
LinkedIn
—
Headquarters
RAMAT GAN
Also known as
Biomotion Sciences
Legal entities
Silexion Therapeutics Corp

Sources

Every material source used to build this profile.

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Additional Nasdaq Staff Determination; Nasdaq Hearings Panel Consideration On September 25, 2026, Silexion Therapeutics Corp (the Company or Silexion ) received a letter from the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, for the 30 consecutive business days preceding the letter, the closing bid price of the Company s ordinary shares, par value $0.135 per share ( ordinary share s ), was below the minimum $1.00 pe…
    View source record

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Silexion Therapeutics Corp — Biological Products, (No Diagnostic Substances) (SIC 2836) — RAMAT GAN, Israel
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On August 18, 2026, Silexion Therapeutics Corp, a Cayman Islands exempted company (the Company , we , us or our ) received a delisting notice from the Nasdaq Listing Qualifications Department in respect of a listing deficiency relating to our non-compliance with the minimum shareholders equity requirement for continued listing on The Nasdaq Capital Market. That delisting notice is subject to the Company s right to request an appeal of the determination before a Nasdaq Hearings Panel (a…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:05 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.